Resource / 13514
unknownUnnamed resource.
Which companies are running clinical trials, and at what stage? Search ClinicalTrials.gov interventional industry-sponsored studies by lead sponsor, phase, status, condition, intervention type, a US state with a site, first-posted date (since), start date, or completion date. Returns the sponsor (entity-resolved where possible), phase, status, conditions, enrollment, and dates — a developer target list for CRO, trial-software, and commercial-ops sellers. ClinicalTrials.gov public records.
| State | Network | Scheme | Atomic amount | Asset | payTo / untrusted |
|---|---|---|---|---|---|
| active | eip155:8453 | exact | 30000 | 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913 | 0x3873d15CF3209c32aaA8d9AA542164E658567129 |
All advertised payment options are stored. Base (`eip155:8453`) is the operational network for ranking and canaries; non-Base options remain visible for transparency.
No probe attempts recorded yet. Coverage runs prioritize never-probed endpoints.
Machine contract
Schemas.
{
"method": "GET",
"queryParams": {
"phase": "PHASE3",
"sponsor": "Regeneron",
"status": "RECRUITING"
},
"type": "http"
}
{
"example": {
"rows": [
{
"collaborators": null,
"completion_date": "2025-02-05",
"conditions": [
"Chronic Plaque Psoriasis"
],
"enrollment": 133,
"entity_id": null,
"first_posted_date": "2023-08-25",
"intervention_types": [
"DRUG",
"OTHER"
],
"interventions": [
"Bimekizumab",
"Placebo"
],
"last_update_date": "2025-03-10",
"nct_id": "NCT06011733",
"overall_status": "COMPLETED",
"phase": "PHASE3",
"primary_completion_date": "2025-02-05",
"site_count": 18,
"sponsor_class": "INDUSTRY",
"sponsor_name": "UCB Biopharma SRL",
"start_date": "2023-10-31",
"study_type": "INTERVENTIONAL"
}
],
"total_matched": 1
},
"type": "json"
}